Sale!

SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test Cost

Name: SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test Cost
SKU: TEST-1584
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test is a specific diagnostic tool aimed at identifying mutations in the SETD5 gene, which are associated with mental retardation autosomal dominant type 23 (MRD23). This condition is characterized by intellectual disabilities, developmental delays, and sometimes physical anomalies. The test is crucial for families seeking to understand the genetic basis of intellectual disabilities in their members, enabling targeted interventions and support.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient’s DNA to detect abnormalities in the SETD5 gene. The process requires a simple sample of the patient’s blood or saliva, which is then examined using advanced genetic sequencing technologies.

The cost of the SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test is 4400 AED. This investment covers the comprehensive analysis necessary to provide a clear genetic diagnosis, which is essential for planning appropriate care and support for affected individuals. Families and healthcare providers opting for this test at DNA Labs UAE can expect results that are both accurate and actionable, contributing significantly to the management of conditions associated with mutations in the SETD5 gene.

Description

SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test

Test Name: SETD5 Gene Mental retardation autosomal dominant type 23 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SETD5 Gene Mental retardation, autosomal dominant type 23 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SETD5 Gene Mental retardation, autosomal dominant type 23.

Test Details:

The SETD5 gene is associated with mental retardation, autosomal dominant type 23 (MRD23). MRD23 is a genetic disorder characterized by intellectual disability, delayed development, and speech and language difficulties. It is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing on the condition to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA to identify genetic variations that may be responsible for a particular condition or disease. In the context of MRD23, NGS genetic testing can be used to detect mutations or variations in the SETD5 gene that may be causative or associated with the disorder.

By performing NGS genetic testing, healthcare professionals can provide a more accurate diagnosis, offer appropriate genetic counseling, and potentially guide treatment and management options for individuals with MRD23.

Test Name	SETD5 Gene Mental retardation autosomal dominant type 23 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SETD5 Gene Mental retardation, autosomal dominant type 23 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SETD5 Gene Mental retardation, autosomal dominant type 23
Test Details	The SETD5 gene is associated with mental retardation, autosomal dominant type 23 (MRD23). MRD23 is a genetic disorder characterized by intellectual disability, delayed development, and speech and language difficulties. It is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing on the condition to each of their children. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA to identify genetic variations that may be responsible for a particular condition or disease. In the context of MRD23, NGS genetic testing can be used to detect mutations or variations in the SETD5 gene that may be causative or associated with the disorder. By performing NGS genetic testing, healthcare professionals can provide a more accurate diagnosis, offer appropriate genetic counseling, and potentially guide treatment and management options for individuals with MRD23.